...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: The Great Tuesday Short Attack

One has to have hug kahuna's to want to short a biotech in pivotal SOC end of  phase 3 trial,  thats at $1.70,  The shorters could get creamed if we get a really postive NR or a major deal of any sort that DM has mentioned in the past, he has come through with deals in the past.....     unless the shorter have inside info which i highly doubt , not sure 3rd eye would have invested 40 $ million Cad if they would certain of decent  results in the trial....

Share
New Message
Please login to post a reply